Session Details

[S2]Radiopharmaceutical Sciences

Wed. Sep 17, 2025 9:35 AM - 10:45 AM JST
Wed. Sep 17, 2025 12:35 AM - 1:45 AM UTC
Hall S(Int’l)

[S2-01(Invited)]Isotope Mass Separation at CERN-MEDICIS :clinical research with High Molar Activity radiotherapeutics

*Thierry Stora1 (1. CERN (Switzerland))

[S2-02]Production of 155Tb via α-particle induced reaction on 153Eu

*Yudai Shigekawa1,2, Ryotaro Masuda3, Sayantani Mitra1, Akihoro Nambu1, Yoshitaka Kasamatsu3, Hiromitsu Haba1 (1. RIKEN (Japan), 2. University of Tsukuba (Japan), 3. Osaka University (Japan))

[S2-03*]Developing robust targetry and radiochemistry of antimony-119 for pre-clinical applications in radioligand therapy

*Aivija Grundmane1,2, Caterina F Ramogida1,2, Valery Radchenko2,3 (1. Simon Fraser University (Canada), 2. TRIUMF (Canada), 3. University of British Columbia (Canada))